Key statistics
On Thursday, Syndax Pharmaceuticals Inc (SNDX:NSQ) closed at 18.63, -26.48% below its 52-week high of 25.34, set on Feb 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 18.35 |
---|---|
High | 19.04 |
Low | 17.85 |
Bid | 18.38 |
Offer | 23.00 |
Previous close | 18.00 |
Average volume | 1.48m |
---|---|
Shares outstanding | 85.10m |
Free float | 83.53m |
P/E (TTM) | -- |
Market cap | 1.53bn USD |
EPS (TTM) | -3.38 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 21:15 BST.
More ▼
- Foundation Medicine Partners with Syndax to Develop a Companion Diagnostic in Hematology and Support Efforts to Pursue Regulatory Approval for an Assay Based on the FoundationOne®Heme Platform
- Incyte and Syndax Announce U.S. FDA Approval of Niktimvo™ (axatilimab-csfr) for the Treatment of Chronic Graft-Versus-Host Disease (GVHD)